Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination

NCT01627938 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Dexrazoxane (DRZ) plus Mitoxantrone (MX)
DRUG: Placebo plus Mitoxantrone (MX)

Sponsor

PD Dr. Andrew Chan